BOSTON, Sept. 30 /PRNewswire-FirstCall/ — Solos Endoscopy, Inc.
(Pink Sheets:
SNDY) is pleased to announce the results of the 2010 annual
shareholder meeting held September 28, 2010 near Solos’
headquarters in Boston, MA. During Solos’ annual shareholder
meeting, Robert Segersten, Amanda Segersten and Fred Schiemann were
re-elected to serve on the Company’s Board of Directors until the
next shareholders meeting. The shareholders also approved the
motion to retain Fred Schiemann, CPA as the Company’s
accountant.
As a part of the Company’s presentation, Robert Segersten,
President of Solos Endoscopy, Inc., outlined the Company’s progress
in satisfying the requirements for the Company’s ISO 13485 quality
management system (QMS) initiative. Mr. Segersten restated that
Solos has successfully completed Phase One requirements and
announced that the Company is diligently working towards completion
of Phase Two requirements, which Solos expects to conclude in the
next six months. The Company also touched upon the further
development and introduction of new products for the fourth
quarter.
“We are excited to serve another term on the Board of Directors
of Solos. The Company continues to implement its strategy of growth
through the development of new products and the eventual
introduction of our product globally,” stated Robert Segersten,
President of Solos Endoscopy, Inc.
About Solos Endoscopy, Inc.:
Solos Endoscopy, Inc. is a HealthCare instrument company whose
mission is to develop and market high quality and innovative
instruments for the screening, diagnosis, treatment and management
of medical conditions. Additional information on its FDA approved
products is available on the Company’s website at:
SOURCE
